TNF and benign prostatic hyperplasia: In the PCa palliative group, the percentage of TNFα-positive cells with strong immunoexpression was significantly higher vs. PCa surgical and BPH patients (p = 0.011 and p = 0.007, respectively) (Figure 4A).